Free Trial

PyroGenesis Canada (PYRGF) Competitors

PyroGenesis Canada logo
$0.32 +0.00 (+1.12%)
As of 03:32 PM Eastern

PYRGF vs. ACB, EDIT, NBTX, IMMP, MNPR, ESPR, FENC, SLRN, PRQR, and TVGN

Should you be buying PyroGenesis Canada stock or one of its competitors? The main competitors of PyroGenesis Canada include Aurora Cannabis (ACB), Editas Medicine (EDIT), Nanobiotix (NBTX), Prima BioMed (IMMP), Monopar Therapeutics (MNPR), Esperion Therapeutics (ESPR), Adherex Technologies (FENC), Acelyrin (SLRN), ProQR Therapeutics (PRQR), and Semper Paratus Acquisition (TVGN). These companies are all part of the "pharmaceutical products" industry.

PyroGenesis Canada vs. Its Competitors

PyroGenesis Canada (NASDAQ:PYRGF) and Aurora Cannabis (NASDAQ:ACB) are both small-cap pharmaceutical products companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, profitability, risk, analyst recommendations, media sentiment, institutional ownership, dividends and earnings.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
PyroGenesis Canada
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Aurora Cannabis
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
2 Strong Buy rating(s)
3.67

0.0% of PyroGenesis Canada shares are held by institutional investors. Comparatively, 47.6% of Aurora Cannabis shares are held by institutional investors. 47.7% of PyroGenesis Canada shares are held by company insiders. Comparatively, 0.0% of Aurora Cannabis shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Aurora Cannabis has higher revenue and earnings than PyroGenesis Canada. PyroGenesis Canada is trading at a lower price-to-earnings ratio than Aurora Cannabis, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
PyroGenesis Canada$9.14M6.65-$21.12M-$0.02-16.23
Aurora Cannabis$246.72M1.02$1.63M$0.1140.73

PyroGenesis Canada has a beta of 0.84, suggesting that its share price is 16% less volatile than the S&P 500. Comparatively, Aurora Cannabis has a beta of 1.75, suggesting that its share price is 75% more volatile than the S&P 500.

In the previous week, Aurora Cannabis had 3 more articles in the media than PyroGenesis Canada. MarketBeat recorded 5 mentions for Aurora Cannabis and 2 mentions for PyroGenesis Canada. Aurora Cannabis' average media sentiment score of 0.61 beat PyroGenesis Canada's score of 0.00 indicating that Aurora Cannabis is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
PyroGenesis Canada
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Aurora Cannabis
0 Very Positive mention(s)
1 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Aurora Cannabis has a net margin of 1.32% compared to PyroGenesis Canada's net margin of -115.14%. Aurora Cannabis' return on equity of 0.13% beat PyroGenesis Canada's return on equity.

Company Net Margins Return on Equity Return on Assets
PyroGenesis Canada-115.14% N/A -60.81%
Aurora Cannabis 1.32%0.13%0.10%

Summary

Aurora Cannabis beats PyroGenesis Canada on 14 of the 16 factors compared between the two stocks.

Get PyroGenesis Canada News Delivered to You Automatically

Sign up to receive the latest news and ratings for PYRGF and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding PYRGF and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

PYRGF vs. The Competition

MetricPyroGenesis CanadaPharmaceutical IndustryIndustrials SectorNASDAQ Exchange
Market Cap$60.80M$752.12M$7.53B$9.32B
Dividend YieldN/A4.84%4.55%4.05%
P/E Ratio-5.411.4325.2119.68
Price / Sales6.6525.51111.46100.29
Price / CashN/A19.5627.4657.53
Price / Book-32.466.604.385.67
Net Income-$21.12M-$4.53M$797.00M$257.51M
7 Day Performance-7.12%1.40%0.51%0.52%
1 Month Performance-7.60%1.30%5.08%8.84%
1 Year Performance-53.94%3.42%26.63%14.18%

PyroGenesis Canada Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
PYRGF
PyroGenesis Canada
0.092 of 5 stars
$0.32
+1.1%
N/A-53.5%$60.80M$9.14M-5.4190News Coverage
Gap Up
ACB
Aurora Cannabis
0.3703 of 5 stars
$4.48
+1.1%
N/A-26.3%$251.82M$246.72M40.731,130
EDIT
Editas Medicine
4.2282 of 5 stars
$2.96
+16.5%
$4.70
+58.8%
-51.0%$247.78M$32.31M-0.97230
NBTX
Nanobiotix
2.3204 of 5 stars
$5.25
+9.6%
$8.00
+52.4%
-3.4%$247.43M$39.18M0.00100Gap Up
IMMP
Prima BioMed
1.5053 of 5 stars
$1.68
flat
$7.00
+316.7%
-20.1%$245.35M$5.14M0.002,021Gap Up
MNPR
Monopar Therapeutics
2.1735 of 5 stars
$39.00
+4.8%
$60.00
+53.8%
+1,020.0%$238.68MN/A-11.2110News Coverage
Insider Trade
ESPR
Esperion Therapeutics
3.9398 of 5 stars
$1.19
+7.2%
$7.00
+488.2%
-54.8%$235.86M$332.31M-1.49200Analyst Revision
FENC
Adherex Technologies
2.4611 of 5 stars
$8.51
+0.5%
$13.00
+52.8%
+33.2%$234.88M$47.54M-16.6910News Coverage
SLRN
Acelyrin
N/A$2.27
flat
$9.60
+322.9%
N/A$229.17MN/A-0.92135
PRQR
ProQR Therapeutics
2.5251 of 5 stars
$2.15
+0.5%
$8.00
+272.1%
+34.9%$226.20M$20.46M-6.14180
TVGN
Semper Paratus Acquisition
4.0981 of 5 stars
$1.22
+1.7%
$10.00
+719.7%
+69.0%$224.33MN/A0.003

Related Companies and Tools


This page (NASDAQ:PYRGF) was last updated on 7/16/2025 by MarketBeat.com Staff
From Our Partners